Balyasny Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-245,624	Closed	-$2.26M	–	2905
2025 Q2	$2.26M	Buy	245,624 +74,241	+43%	+$634K	﹤0.01%	1672
2025 Q1	$1.47M	Buy	+171,383	New	+$1.62M	﹤0.01%	1842
2024 Q3	–	Sell	-24,349	Closed	-$103K	–	2735
2024 Q2	$103K	Sell	24,349 -58,731	-71%	-$238K	﹤0.01%	2402
2024 Q1	$423K	Buy	83,080 +13,779	+20%	+$77.6K	﹤0.01%	2117
2023 Q4	$645K	Buy	69,301 +44,030	+174%	+$303K	﹤0.01%	1842
2023 Q3	$166K	Sell	25,271 -18,882	-43%	-$150K	﹤0.01%	2059
2023 Q2	$359K	Buy	44,153 +13,878	+46%	+$119K	﹤0.01%	1945
2023 Q1	$259K	Sell	30,275 -28,706	-49%	-$287K	﹤0.01%	2168
2022 Q4	$546K	Buy	58,981 +1,884	+3%	+$20.1K	﹤0.01%	1836
2022 Q3	$589K	Buy	+57,097	New	+$603K	﹤0.01%	1985
2017 Q4	–	Sell	-14,616	Closed	-$61K	–	2048
2017 Q3	$61K	Buy	+14,616	New	+$65K	﹤0.01%	1806
2016 Q2	–	Sell	-20,050	Closed	-$98K	–	1157
2016 Q1	$98K	Buy	+20,050	New	+$88.2K	﹤0.01%	1201